Risk of cancer in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) compared with the Swedish general population Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement? Year: 2020
Mortality in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) Source: Eur Respir J 2006; 28: Suppl. 50, 144s Year: 2006
Alpha-1-antitrypsin deficiency patients (AATD): two-year follow-up Source: Eur Respir J 2002; 20: Suppl. 38, 260s Year: 2002
Characterization of a population of alpha1 -antitrypsin deficient (A1 ATD) patients Source: Annual Congress 2008 - COPD Year: 2008
Clinical, functional, radiologic and quality of life characteristics in PI*SZ Alpha 1-Antitrypsin Deficiency (AATD) compared to PI*ZZ, PI*MZ and COPD without AATD: a retrospective cohort study. Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021
Prevalence of alpha-1-antitrypsin deficiency (A1AD) in patients with COPD. Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021
Serum TNFα, CD14 and CRP levels in COPD patients with different alpha-1 antitrypsin phenotypes Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008
Clinical consequences and longitudinal outcomes in PiMZ heterozygous a1-antitrypsin deficiency smokers from SPIROMICS Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD Year: 2021
Alpha1-antitrypsin blood levels and lung function in the population-based SAPALDIA cohort Source: Eur Respir J 2005; 26: Suppl. 49, 219s Year: 2005
Lung function at the age of 35 years in individuals with alpha-1-antitrypsin deficiency identified by neonatal screening Source: Annual Congress 2010 - The impact of genes and environment on obstructive airway diseases Year: 2010
Differences of disease phenotypes in individuals with alpha-1-antitrypsin deficiency with genotypes PiZZ and PiSZ - Analysis from the German registry Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016
Factors associated with testing of COPD patients for serum AAT levels to detect cases of AATD. The EPOCONSUL study. Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018
The incidence of alpha-1-antitrypsin (A1AT) deficiency alleles in Polish population – Results from the ongoing newborn screening Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013
Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits Source: Eur Respir J, 50 (3) 1700198; 10.1183/13993003.00198-2017 Year: 2017
Alpha1-antitrypsin levels and phenotypes in COPD patients in Kyrgyz population Source: Annual Congress 2008 - Pathophysiology of COPD Year: 2008
Serum levels of TGFβ and VEGF in lung cancer patients and healthy subjects Source: Eur Respir J 2004; 24: Suppl. 48, 43s Year: 2004
Differences in migrating neutrophils from patients with COPD compared with healthy smokers and non smokers and patients with alpha 1 antitrypsin deficiency Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010
Plasma adiponectin and risk of asthma: observational and Mendelian randomization studies in up to 557,801 individuals Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021
Baseline characteristics of patients enrolled in the EARCO prospective registry of alpha-1 antitrypsin deficiency: preliminary results. Source: Virtual Congress 2021 – Treatments for airway diseases Year: 2021